CRL shareholders approve 2026 LTIP, re-elect all 12 directors

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

2026 Long-Term Incentive Plan approved with 41.5M for vs 2.6M against; 4.825M shares authorized.
All 12 director nominees elected; Abraham Ceesay received highest withhold (8.3M against).
Advisory say-on-pay passed with 41.4M for vs 2.7M against, 1.7M broker non-votes.
Ratification of PricewaterhouseCoopers as auditor approved with 43.6M for vs 2.2M against.

item 5.02item 5.07item 9.01

Source: SEC EDGAR

accession 0000950103-26-007060

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.